Evidence map›Paper›PMID 32921997›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2020

Li-Jun Chen, Wang Xu, Ya-Ping Li, Li-Ting Ma, Hui-Fang Zhang, Xiao-Bo Huang, Geng-Geng Yu, Xiu-Qin Ma, Chao Chen, Yan-Hong Liu and 3 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04955977 (Effects of a Physical Exercise Program on the Responses Measured by HIF-1 Related to Ventilatory and Hematological Function in Patients With COPD Resident at 2600 m.s.n.m.), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04955977 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Effects of a Physical Exercise Program on the Responses Measured by HIF-1 Related to Ventilatory and Hematological Function in Patients With COPD Resident at 2600 m.s.n.m.

TypeinterventionalSponsorUniversidad Nacional de ColombiaRan2022 to 2022Enrolled33ConditionsPulmonary Disease, Chronic ObstructiveArmsPhysical exercise program, Health education in COPD
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Current pharmaceutical design · 2024
    Article
  5. Exercise performance reduction and preventive measures in highland sports.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Li-Jun ChenDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.ORCID 0000-0002-8494-2227
Wang XuDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Ya-Ping LiDepartment of Respiratory Medicine, Weihai Municipal Hospital of Shandong Province, Weihai, Shandong, People's Republic of China.
Li-Ting MaDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Hui-Fang ZhangDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Xiao-Bo HuangDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Geng-Geng YuDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Xiu-Qin MaDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Chao ChenDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Yan-Hong LiuDepartment of Respiratory and Critical Medicine, The First People's Hospital of Yinchuan City, Yinchuan, Ningxia, People's Republic of China.
Jie WuDepartment of Clinical Institute, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China.
Li-Jun WangDepartment of Clinical Institute, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China.
Yuan XuDepartment of Clinical Institute, Ningxia Medical University, Yinchuan, Ningxia, People's Republic of China.
Yinchuan First People's Hospital · CNNingxia Medical University · CNWeihai Municipal Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a chronic airway inflammatory disease characterized by irreversible airflow obstruction. Pathogenic mechanisms underlying COPD remain largely unknown. Objective: The current study was designed to explore serum concentration of hypoxia-inducible factor 1α (HIF-1α) in stable COPD patients and the potential effect of Methods: Serum HIF-1α was quantified by ELISA in 102 stable COPD patients before and after 2-week orally taken LBP (100 mL/time, twice daily, 5-15 mg/mL). Correlation of serum LBP and lung function (FEV1%) or blood gas (PO Results: Serum concentration of HIF-1α was significantly higher in the stable COPD patients (37.34 ± 7.20 pg/mL) than that in the healthy subjects (29.55 ± 9.66 pg/mL, Conclusion: These findings suggested that activation of HIF-1 signaling pathway may be involved in the pathophysiology of COPD and that stabilization of serum HIF-1α concentration by LBP might benefit the stable COPD patients.

Indexed as

Drugs, Chinese HerbalPulmonary Disease, Chronic ObstructiveHumansHypoxia-Inducible Factor 1Hypoxia-Inducible Factor 1, alpha SubunitLungDrugs, Chinese HerbalHypoxia-Inducible Factor 1Hypoxia-Inducible Factor 1, alpha Subunitlycium barbarum polysaccharidechronic obstructive pulmonary diseaseCOPDHIF-1hypoxia-induced factor 1LBPLycium barbarum polysaccharides

Identifiers

PMID32921997
PMCPMC7455768
OpenAlexW3080605190

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.